You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: ontology/oae.md
+15-15Lines changed: 15 additions & 15 deletions
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -15,7 +15,7 @@ license:
15
15
url: http://creativecommons.org/licenses/by/4.0/
16
16
preferredPrefix: OAE
17
17
products:
18
-
- id: oae.owl
18
+
- id: oae.owl
19
19
repository: https://github.com/OAE-ontology/OAE
20
20
tags:
21
21
- adverse events
@@ -29,31 +29,31 @@ publications:
29
29
title: The Ontology of Adverse Events in 2025
30
30
31
31
usages:
32
-
- description: Using OAE to support the classification and analysis of VAERS vaccine adverse event reporting system data analysis.
32
+
- description: Using OAE to support the classification and analysis of VAERS vaccine adverse event reporting system data analysis.
33
33
examples:
34
-
- description: OAE was used to analyze and differentiate adverse events associated with inactivated and live attenuated influenza vaccines reported in VAERS
35
-
url: https://pubmed.ncbi.nlm.nih.gov/23209624/
36
-
- description: OAE was used to analyze COVID-19 vaccine adverse events reported in VAERS
34
+
- description: OAE was used to analyze and differentiate adverse events associated with inactivated and live attenuated influenza vaccines reported in VAERS
35
+
url: https://pubmed.ncbi.nlm.nih.gov/23209624/
36
+
- description: OAE was used to analyze COVID-19 vaccine adverse events reported in VAERS
37
37
urls:
38
38
- https://pubmed.ncbi.nlm.nih.gov/35814246/
39
39
- https://pubmed.ncbi.nlm.nih.gov/41971073/
40
-
- description: OAE was used to analyze adverse events associated with monovalent and combination vaccines against Hepatitis A and B diseases reported in VAERS
40
+
- description: OAE was used to analyze adverse events associated with monovalent and combination vaccines against Hepatitis A and B diseases reported in VAERS
41
41
url: https://pubmed.ncbi.nlm.nih.gov/27694888/
42
-
43
-
- description: Using OAE to analyze vaccine adverse event using FDA vaccine package insert documents
42
+
43
+
- description: Using OAE to analyze vaccine adverse event using FDA vaccine package insert documents
44
44
examples:
45
45
- description: OAE was used to unveil differential vaccine adverse events via LLM text embeddings of FDA vaccine package insert documents
46
46
url: https://pubmed.ncbi.nlm.nih.gov/40410898/
47
-
48
-
- description: Using OAE to analyze vaccine adverse events reported in PubMed papers
47
+
48
+
- description: Using OAE to analyze vaccine adverse events reported in PubMed papers
49
49
examples:
50
-
- description: OAE was used to classify human and animal adverse events associated with different Brucella animal vaccines as reported in PubMed literature
50
+
- description: OAE was used to classify human and animal adverse events associated with different Brucella animal vaccines as reported in PubMed literature
- description: The VIOLIN vaccine safety database (Vaxafe) uses OAE to map adverse event information in vaccine adverse event case reports, for example, Vaxafe uses OAE to represent many adverse events (such as Convulsion, Cough) reported in a VAERS case ID - 204308.
- description: The VIOLIN vaccine safety database (Vaxafe) uses OAE to map adverse event information in vaccine adverse event case reports, for example, Vaxafe uses OAE to represent many adverse events (such as Convulsion, Cough) reported in a VAERS case ID - 204308.
0 commit comments